A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride

Pharmaceutical Research

Volumn 14, Issue 10, 1997, Pages 1415-1421

  Kim, Hyunjo ^a   Fassihi, Reza ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Controlled drug delivery; Diltiazem hydrochloride; Gelatin system; Highly soluble drugs; HPMC; Pectin; Simple hydrophilic matrix; Ternary polymeric system

Indexed keywords

BENZOTHIAZEPINE DERIVATIVE; DILTIAZEM; GELATIN; PECTIN; POLYMER;

ARTICLE; DELIVERY; DIFFUSION; DISSOLUTION; DRUG RELEASE; DRUG TRANSPORT; HUMAN; HYDRODYNAMICS; MATRIX TABLET; POLYMERIZATION; PRIORITY JOURNAL; TABLET; TRANSPORT KINETICS;

DELAYED-ACTION PREPARATIONS; DILTIAZEM; DRUG DELIVERY SYSTEMS; GELATIN; KINETICS; METHYLCELLULOSE; PECTINS; SOLUBILITY; TABLETS;

EID: 0030829660     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012124806316     Document Type: Article

References (26)

1. United State Patent No. 4,839,177 (1989).
2. U. Conte, L. Maggi, and A. La Manna. S.T.P. Pharma. Sciences. 412:107-113 (1994).
3. K. Heilmann. Therapeutic Systems, Rate-Controlled Drug Delivery: Concept and Development, 2nd ed., Thieme-Stratton, New York, 50p 1984.
4. B. Eckenhoff, F. Theeuwes, and J. Urquhart. Pharm. Techn. 5:35-44 (1881).
5. L. Yang and R. Fassihi. J. Pharm. Sci. 85:170-173 (1996).
6. M. Sato, T. Nagao, I. Yamaguchi, H. Nakajima, and A. Kiyomoto. Arzneim.-Forsch. 21:1338-1343 (1971).
7. M. S. Smith, C. P. Verghese, D. G. Shand, and E. L. C. Pritchett. Am. J. Cardiol. 51:1369-1374 (1983).
8. L. M. Prisant, B. Bottini, J. T. Dipiro, and A. A. Carr. Am. J. Med. 93 (suppl 2A):45S-55S (1992).
9. M. Gibaldi. Pharmaceutical News. 3:8-12 (1996).
10. J. G. Wagner. Drug. Stand. 28:30-34 (1960).
11. T. Higuchi. J. Pharm. Sci. 52:1145-1149 (1963).
12. A. W. Hixson, J. H. Crowell. Ind. Eng. Chem., 23:923-927 (1931).
13. G. Xu and H. Sunada. Chem. Pharm. Bull. 43:483-487 (1995).
14. H. Kim, A. R. Fassihi. J. Pharm. Sci. 86:316-322 (1997).
15. H. Kim, A. R. Fassihi. J. Pharm. Sci. 86:323-328 (1997).
16. S. C. Sutton, K. Engle, R. A. Deeken, K. E. Pluteand R. D. Shaffer. Pharm. Res. 8:84-87 (1991).
17. L. Yang and A. R. Fassihi. J. Control. Rel. 11:135-140 (1996).
18. R. T. C. Ju, P. R. Nixon, M. V. Patel, and M. Tong. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 22:59-60 (1995).
19. P. L. Ritger and N. A. Peppas. J. Cont. Rel. 5:37-42 (1987).
20. P. Colombo, R. Bettini, R.; G. Massimo, P. L. Catellani, P. Santi, and N. A. Peppas. J. Pharm. Sci. 84:991-997 (1995).
21. W. D. Lindner and B. C. Lippold. Pharm. Res. 12:1781-1785 (1995).
22. A. T. Pham and P. I. Lee. Pharm. Res. 11:1379-1384 (1994).
23. N. A. Peppas and J. J. Sahlin. Int. J. Pharm. 57:169-172 (1987).
24. A. R. Beren and H. B. Hopfenberg. Polymers. 19:489 (1978).
25. W. Sutananta, D. Q. M. Craig, and J. M. Newtons. J. Pharm. Pharmcol. 47:182-187 (1995).
26. D. L. Wolfram and C. L. Bernhard. Pharm. Res. 12:1781-1785 (1995).